Canna Law Blog

FEBRUARY 25, 2022

If you keep a pulse on this issue, you know that for the past three years, the FDA has held the position that CBD cannot be marketed as a dietary ingredient because it was first studied and approved as a drug ingredient in GW Pharmaceuticals’ Epidiolex ( Drug Exclusion Rule ). According to NPA’s petition, the U.S.

CBD 80

CBD Safety Data Food 80

United Patients Group

MAY 17, 2023

Some researchers believe that cannabinoids may help people with ASD manage anxiety and stress by increasing their ability to focus and pay attention. Cannabinoids have been shown to help people with autism manage anxiety and stress.

Sleep 80

Sleep Cannabinoids Patients CBD 80

Cannabis Law Report

MARCH 29, 2022

to acquire Dutch medical cannabis company APIRx Pharmaceutical BV. Incannex was one of the first ASX-listed companies to make forays into cannabinoid and psychedelic therapeutic drugs (it was originally a direct-to-consumer dental business, which disrupted the dental space).

Pharmaceutical 52

Pharmaceutical Cannabinoids Data Policy 52

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

JUNE 7, 2019

The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. Cannabinoids are chemical compounds found in the cannabis plant. The Straits Times Reports.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

PrestoDoctor

SEPTEMBER 6, 2023

The plant’s active compounds, cannabinoids, interact with the body’s endocannabinoid system, which plays a crucial role in regulating pain perception. One of the primary reasons for this shift is the growing acceptance and accessibility of cannabis as an alternative pain management option.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Cannabis Law Report

SEPTEMBER 20, 2021

provides Heritage and subsidiary Opticann the benefits of offering patients access to safe, convenient, and effective CB4 products developed on trusted technology platforms. The products leverage pharmaceutical technology to maximize performance and safety. TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

The Cannigma

JUNE 14, 2021

We are allowed to cultivate, manufacture, research, analyze and distribute cannabis for scientifical, medical and pharmaceutical research. Second, it can change the content of both THC and potentially other cannabinoids and third, hopefully it will allow for testing different delivery methods.”. Shutterstock). A promise made years ago.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

MARCH 17, 2022

It is significant to cite that cannabinoids are mainly from rural weed grains for therapeutic goals. Another phase in discovering the best-quality weed herbal commodities is purchasing the ideal mix of cannabinoids and other weed-based components. Cannabis strains are accessible in different formulations. Cannabinoid Content.

CBD 52

CBD Extraction Cannabinoids Strains 52

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Cannabinoids Epilepsy THC 74

Cannabis Law Report

NOVEMBER 22, 2019

. “As MMJ International Holdings continues to advance to its clinical trials, a specialty pharmaceutical solutions company will be supporting MMJ with the FDA, DEA required development API and specialized liquid encapsulation solutions,” said Elio Mariani, PhD, EVP of Research & Development. Orphan Drug Designation?

DEA 66

DEA Clinical Trials THC Research and Development 66

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not. This system naturally produces cannabinoids in the bloodstream, but chronic stress, anxiety, and other stimuli can stifle the production of natural endocannabinoids.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

DECEMBER 1, 2019

MHA, without elaborating on the girl’s age, the specific medication and her current condition, said: “Given the patient’s condition, her doctor applied to the Health Sciences Authority (HSA) to bring in a cannabinoid pharmaceutical, considering that the treatment might address the unmet medical need.”. Full story [link].

Epilepsy 59

Epilepsy Cannabinoids Therapy Treatment 59

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). It allows patients to have access to medicinal cannabis without danger of being criminalized. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

CannaMD

NOVEMBER 6, 2019

And so, in light of America’s ongoing struggle with a sweeping opioid crisis of addiction and overdose deaths, it makes sense that there is a growing interest both among the public and the medical community in the possibilities of medical marijuana as an alternative to pharmaceuticals for pain management. percent, respectively.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

Cannabis Info

MARCH 2, 2019

Cannabis is being viewed as a potential treatment for epileptic seizures and large success has been witnessed so far, triggering a large movement of people and organisations who are in favour of its access and medicinal use. The non-psychoactive cannabinoid CBD has gained massive attention due to its apparent positive effects on seizures.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

JUNE 9, 2022

Steph Sherer, Founder and President, Americans for Safe Access. 3:15-4:15 PM: Preventing Youth Access, Promoting Consumer Safety, & Protecting Public Health in State Markets. 4:15-5:00 PM: How Data and Technology can help future policy making: Public Health, Regulatory, and Industry Data Sources. Hemp Roundtable.

Policy 52

Policy Safety Seed-To-Sale Data 52

Cannabis Law Report

OCTOBER 14, 2021

The study, conducted independently by Colorado State University researchers and published in the peer-reviewed, open-access scientific journal Pharmaceuticals , explored the pharmacokinetics of edible THC. The FDA keeps asking for ‘real world evidence’ on consumer cannabinoid products.

THC 52

THC Edibles Cannabinoids Data 52

Cannabis Law Report

NOVEMBER 24, 2019

Building the bridge between brands and the marketplace through testing and the importance of good data. A need for data at all of these levels and data specific to product type drives more advanced methodology in the laboratories, often resulting in a better understanding of the matrix and more accurate data.

Business 95

Business Data Wellness and Beauty Safety 95

SpeedWeed

MARCH 13, 2021

Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. Preclinical evidence suggests that cannabinoids could be widely beneficial to neurodegenerative diseases, including PD.”. After analyzing the data, the researchers found that 24.5%

Patients 52

Patients Treatment Therapy Sleep 52

Veriheal

AUGUST 31, 2020

Essay Summary: Although doctors’ offices are full of pamphlets and flyers about mainstream pharmaceuticals in both English and Spanish, there is a lack of information for Hispanic patients seeking relief with cannabis and CBD. . Essay: “Combining Social Sciences and Pharmacology to Make a Positive Social Impact in Cannabis” .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Info

MARCH 21, 2019

There are numerous companies providing ancillary services to the industry, as well as many derivative plays, like pharma and biotech companies making cannabinoid-based drugs and service/product providers that used to operate outside the marijuana industry but have gotten on board since legalization. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH).

Marijuana 59

Marijuana Pharmaceutical Hash Cannabinoids 59

CannaTech

AUGUST 9, 2018

It wasn’t until the second time that I tried CBD, that I forgot to take my usual pharmaceutical anti-epileptic medication. Unlike me, she is based in the UK, and therefore we still don’t have access to medical cannabis for her. But the main push stems from our fight to gain access to this medicine for my sister Tamsin.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Cannabis Law Report

NOVEMBER 23, 2021

The Company has state-of-the-art cultivation facilities in Portugal and Germany that supply pharmaceutical-grade medical cannabis across international markets, as well as sales and distribution arrangements to supply cannabis through major pharmaceutical distribution channels. .: In the E.U., when the time comes.

Research and Development 52

Research and Development Cultivation Pharmaceutical Packaging 52

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

In reality, people using marijuana during this time may have been self-medicating for a mental condition, choosing to use a different coping mechanism than the pharmaceuticals available at the time, pursuing better sleep, or simply enjoying a nontraditional method of increasing productivity and creativity. There is just no way!

Marijuana 52

Marijuana Research and Development Sleep Strains 52

SpeedWeed

AUGUST 19, 2021

In recent months, a synthetic compound derived from hemp called THC-O acetate—often referred to simply as THC-O (pronounced “THC oh”)—has quickly gained popularity among Americans who don’t have access to legal cannabis. . THC-O products are increasingly popular in states where consumers don’t have access to legal cannabis.

THC 52

THC Hemp Extraction Vaping 52

Cannabis Law Report

AUGUST 19, 2019

Cannabinoids are the chemical substances found in cannabis. Over 100 different cannabinoids have been linked to the cannabis plant. No data is available regarding prescriptions written in respect of secondary care. What substances are at issue? Pure CBD is not a controlled drug under the Act or the Regulations.

Environment 45

Environment Food Seed-To-Sale Medicine 45

Cannabis Law Report

DECEMBER 9, 2019

After all, CBD is only one of the hundreds of documented cannabinoids found in cannabis and hemp. Not only are they affordable, but they are also perceived as healthier alternatives to what are sometimes harsh and expensive pet pharmaceuticals with numerous side effects. The Health Potential of this All-Natural Compound.

Pets 59

Pets CBD Research and Development Epilepsy 59

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. Ability to provide appropriate research data. Criterion 3. Criterion 5. Criterion 7. 100 pts .

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JULY 20, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. Ability to provide appropriate research data. Criterion 3. Criterion 5. Criterion 7. 100 pts .

Law 40

Law Marijuana Education Cultivation 40

The Cannigma

AUGUST 5, 2022

When antidepressants were first introduced in the mid-20 th century, they were a breakthrough in pharmaceuticals. Though hope remains for using cannabinoids to treat depression, in human studies THC has often been more associated with depressive behavior. But for thousands of people, these little pills aren’t enough.

Treatment 138

Treatment Research and Development Therapy Digestion 138

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. 2016 ; Sznitman et al. years (Atakan 2012 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JANUARY 14, 2022

Is it a natural response to the fact that recreational is supposedly on the way or a the report suggests it’s hard as a patient to access so therefore people are just giving up. The current lack of market growth reflects an unfortunate reality in Germany that patient access to medical cannabis is still quite low.

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52